ask why
Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

The papers that matter: 4 May to 10 May 2026

The 10 most important of the 139 papers published that week and summarised on Y, ranked by what verified readers said would change practice, then by strength of design and size. Secondary analyses come last.
Urology · Eur Urol · 2026-05-05

Meta-analysis of 5 RCTs (721,607 participants, 11-23 years' follow-up): PSA-based screening vs no screening or usual care reduced prostate cancer-specific mortality at longest follow-up (high-certainty evidence), with greater reduction at longer follow-up.

Meta-analysisn = 721,607
Nguyen et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Urology · World J Urol · 2026-05-06

Meta-analysis of 17 studies (45,603 patients): overall and major complications after PCNL did not differ significantly between elderly and younger patients, but sepsis was higher in the elderly (OR 3.94); in studies using a 70-year cut-off, complications were higher.

Meta-analysisn = 45,603 patients
Nowak et al. Safety and efficacy of percutaneous nephrolithotomy in elderly patients: a systematic review and meta-analysis by the EAU-YAU urolithiasis and EAU endourology sections

Previous weekNext weekAll weeks

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.